Trial Profile
A Double Blind, Randomized, Parallel Group, Prospective, Multicentre Clinical Trial for Evaluation of Efficacy and Safety of IN-AQUL-001 in Comparison with Zopiclone in Adult and Elderly Patients with Primary Insomnia.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 29 Aug 2016
Price :
$35
*
At a glance
- Drugs IN AQUL 001 (Primary) ; Zopiclone
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Intas Pharmaceuticals
- 25 Dec 2010 New trial record